Pfizer CEO: Increase R&D efficiency to boost innovation

07/28/2008 | Bloomberg

Drugmakers need to boost "efficiencies in research and development" to bolster innovation, Pfizer CEO Jeff Kindler told Bloomberg Television. Kindler's decision to divide Pfizer's R&D operation into smaller therapeutic units helped replenish its pipeline, which may have as many as 28 treatments in late-stage development by the end of 2009.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
Minneapolis, MN